AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,143,355 | +129.5% | 714,578 | +111.8% | 0.00% | +100.0% |
Q2 2023 | $15,749,472 | +94.7% | 337,320 | +59.5% | 0.00% | +100.0% |
Q1 2023 | $8,091,000 | +80439.5% | 211,468 | +15.4% | 0.00% | 0.0% |
Q4 2022 | $10,046 | -99.9% | 183,315 | -22.2% | 0.00% | 0.0% |
Q3 2022 | $8,020,000 | +261.4% | 235,529 | +0.3% | 0.00% | – |
Q2 2022 | $2,219,000 | +240.9% | 234,827 | +412.0% | 0.00% | – |
Q1 2022 | $651,000 | -35.6% | 45,867 | -4.1% | 0.00% | – |
Q4 2021 | $1,011,000 | -7.3% | 47,824 | -2.1% | 0.00% | – |
Q3 2021 | $1,091,000 | -13.8% | 48,830 | -4.2% | 0.00% | – |
Q2 2021 | $1,265,000 | -9.3% | 50,969 | +6.1% | 0.00% | – |
Q1 2021 | $1,394,000 | +16.1% | 48,036 | +3.2% | 0.00% | – |
Q4 2020 | $1,201,000 | -34.2% | 46,545 | -20.0% | 0.00% | – |
Q3 2020 | $1,826,000 | +15.6% | 58,184 | -8.3% | 0.00% | – |
Q2 2020 | $1,580,000 | +45.5% | 63,421 | +23.8% | 0.00% | – |
Q1 2020 | $1,086,000 | -53.7% | 51,249 | -51.5% | 0.00% | – |
Q4 2019 | $2,347,000 | +22.8% | 105,730 | +25.9% | 0.00% | – |
Q3 2019 | $1,911,000 | – | 83,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |